Olympus

7733 · TSE · JPY

1 958,00 ¥Variation par rapport à la clôture précédente: −2,51 %Variation absolue: −50,50 ¥

Clôture · 2 octobre 2026

Profil de la société

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Medical Devices
Pays
Japon
Siège
2951 Ishikawa-machi, 192-8507, Hachioji
Salariés
28 138
Cotation
7733 · TSE
Indices
Nikkei 225
Devise
JPY